Hostname: page-component-8448b6f56d-gtxcr Total loading time: 0 Render date: 2024-04-24T22:57:25.324Z Has data issue: false hasContentIssue false
  • English
  • Français

X-ray powder diffraction data for levetiracetam

Published online by Cambridge University Press:  10 October 2013

Kai Lin Xu ,
Bing Liang ,
Xiao Qing Wu ,
Li Li Zhang ,
Pei Xiao Tang  and
Hui Li
Kai Lin Xu
Affiliation:
College of Chemical Engineering, Sichuan University, Chengdu 610065, China
Bing Liang
Affiliation:
College of Chemical Engineering, Sichuan University, Chengdu 610065, China
Xiao Qing Wu
Affiliation:
College of Chemical Engineering, Sichuan University, Chengdu 610065, China
Li Li Zhang
Affiliation:
College of Chemical Engineering, Sichuan University, Chengdu 610065, China
Pei Xiao Tang
Affiliation:
College of Chemical Engineering, Sichuan University, Chengdu 610065, China
Hui Li*
Affiliation:
College of Chemical Engineering, Sichuan University, Chengdu 610065, China
*
a)Author to whom correspondence should be addressed. Electronic mail: lihuilab@sina.com
Get access Rights & Permissions [Opens in a new window]

Abstract

Experimental X-ray powder diffraction data, unit-cell parameters, and space group for levetiracetam, C8H14N2O2, are reported [a = 9.197(5) Å, b = 8.006(0) Å, c = 6.289(3) Å, β = 108.457(3)°, unit-cell volume V = 439.261 Å3, Z = 2, and space group P21]. All measured lines were indexed and are consistent with the P21 space group. No detectable impurity was observed.

Keywords

X-ray powder diffractionlevetiracetam
Type
New Diffraction Data
Information
Powder Diffraction , Volume 29 , Issue 1 , March 2014 , pp. 51 - 52
Copyright
Copyright © International Centre for Diffraction Data 2013 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Engel, G. E., Wilke, S., König, O., Harris, K. D. M., and Leusen, F. J. J. (1999). “Powder Solve–a complete package for crystal structure solution from powder diffraction patterns,” J. Appl. Crystal. 32, 1169–1179.Google Scholar
Gualtieri, F., Manetti, D., Romanelli, M., and Ghelardini, C. (2002). “Design and study of piracetam-like nootropics, controversial members of the problematic of cognition-enhancing drugs,” Curr. Pharm. Des. 8, 125–138.Google Scholar
Haria, M., and Balfour, J. A. (1997). “Levetiracetam,” CNS Drugs. 7, 159–164.Google Scholar
Harris, K. D. M. (2012). “Powder diffraction crystallography of molecular solids,” Top. Curr. Chem. 315, 133–178.Google Scholar
Song, J., Lou, K. X., Li, X. J., Wu, X. P., and Feng, R. X. (2003). “2-(2-Oxopyrrolidin-1-yl) butyramide,” Acta Crystallogr., Sect. E (structure Rep. Online). 59, 1772.Google Scholar
Young, R. A. (1993). The Rietveld Method, IUCr Monographies of Crystallography (Wiley, Oxford).Google Scholar
Zhang, L. L., Pan, Q. Q., Xiao, D., Wu, X. Q., Wang, Q., and Li, H. (2013). “X-ray powder diffraction data for deoxyschisandrin,” Powder Diffr. 28, 231–233.Google Scholar